Is chronic pain an extraintestinal manifestation of IBD?

Inflammatory Bowel Diseases

Volumn 15, Issue 5, 2009, Pages 769-771

  Siegel, Corey A ^a   MacDermott, Richard P ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INFLIXIMAB; NARCOTIC AGENT; ROFECOXIB;

ABDOMINAL PAIN; ANALGESIA; ANXIETY; ANXIETY DISORDER; CHRONIC PAIN; COMORBIDITY; CROHN DISEASE; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; ENDOSCOPY; ENTERITIS; HUMAN; HYPERSENSITIVITY REACTION; INFLAMMATION; IRRITABLE COLON; NARCOTIC DEPENDENCE; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; SEX DIFFERENCE; TREATMENT RESPONSE;

CHRONIC DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; PAIN;

EID: 67650317709     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20844     Document Type: Editorial

References (11)

1. Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol. 2006;4:621-630.
2. Hanson KA, Loftus EV, Harmsen WS, et al. Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: a case-control study. Inflamm Bowel Dis. 2008.
3. Bielefeldt K, Davis B, Binion DG. Pain and inflammatory bowel disease. Inflamm Bowel Dis. 2008.
4. Bernstein CN, Niazi N, Robert M, et al. Rectal afferent function in patients with inflammatory and functional intestinal disorders. Pain. 1996;66:151-161.
5. WHO definition of health. Available at: http://www.who.int/about/ definition/en/print.html. Accessed October 26, 2008.
6. Biancone L, Tosti C, Geremia A, et al. Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial. Aliment Pharmacol Ther. 2004;19:755-764.
7. Bjorkkjaer T, Brunborg LA, Arslan G, et al. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scand J Gastroenterol. 2004;39:1088-1094.
8. Herfarth H, Obermeier F, Andus T, et al. Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease. Am J Gastroenterol. 2002;97:2688-2690.
9. Cunningham AL, Breuer J, Dwyer DE, et al. The prevention and management of herpes zoster. Med J Aust. 2008;188:171-176.
10. Suleiman S, Johnston DE. The abdominal wall: an overlooked source of pain. Am Fam Physician. 2001;64:431-438.
11. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480-1491.